Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Brentuximab Vedotin × Clear all

Sponsor

Conditions

Hodgkin Disease 24 Lymphoma 14 Lymphoma, Large-Cell, Anaplastic 12 Hematologic Diseases 10 Recurrence 8 Lymphoma, T-Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphatic Diseases 3 Leukemia 3 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Histologic Type 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia, Myeloid, Acute 2 Immunoproliferative Disorders 2 Immunoblastic Lymphadenopathy 2 Immune System Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Testicular Neoplasms 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nonseminomatous germ cell tumor 1 Myelodysplastic Syndromes 1 Mastocytosis, Systemic 1

Interventions

Carboplatin 21 Cisplatin 14 pembrolizumab 12 Paclitaxel 12 Gemcitabine 12 Pemetrexed 9 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 6 durvalumab 5 Fluorouracil 5 Docetaxel 5 Cyclophosphamide 5 Axitinib 5 Albumin-Bound Paclitaxel 5 osimertinib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 vosaroxin 2 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡